January 21, 2022
1 min read
Save
ACTIV-4A
Issue: January 2022
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
P2Y12 inhibitor plus anticoagulation vs. anticoagulation alone in noncritically ill patients with COVID-19.